Nachrichten zur Astellas Pharma Inc. Aktie

-Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to CytomX-...…

BASEL (dpa-AFX) - Sandoz said it has entered into an agreement to acquire worldwide product rights for systemic antifungal agent…

TOKYO, Jan. 23, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

Basel, January 24, 2023 – Sandoz, the global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to…

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) said Friday that the U.S. Food and Drug Administration has lifted the…

TOKYO, Jan. 20, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TOKYO, Jan. 19, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced…

NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Antibiotics market insights - Vendors: 15+, Including Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals…

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Selecta Biosciences Shares Rise 11% After Licensing Deal With Astellas Pharma...…

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Next-generation IgG protease candidate Xork to be licensed for development with AT845, an investigational Astellas Gene Therapies product, for the…

Pharma - Basilea erhält eine Meilensteinzahlung vom Partner Astellas....…

Ad hoc announcement pursuant to Art. 53 LR...…

Ad hoc-Mitteilung gemäss Art. 53 KR...…